 Home > Active Ingredient News > Antitumor Therapy > Kangfang bio-anti-PD-1/CTLA-4 dual-specific antibodies to treat metastatic cervical cancer, obtained the FDA rapid designation.

Kangfang bio-anti-PD-1/CTLA-4 dual-specific antibodies to treat metastatic cervical cancer, obtained the FDA rapid designation.

 Last Update: 2020-09-04
 Source: Internet
 Author: User

Tags

anti microsomal antibody

phase locked loop

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Akeso, announced that the U.S. Food and Drug Administration (FDA) has awarded its new anti-PD-1/CTLA-4 dual-specific antibody AK104 fast-track designation as a single therapy for patients with relapsed or metastatic squamous cervical cancer who develop the disease after platinum chemotherapy.
photo source: AK104 is a new humanized IgG1 tetra-specific antibody developed in-house by Akeso to prioritize the binding of tumor-immersed lymphocytes over normal exome lymphocytes.
AK104 is based on Akeso's proprietary "TETRABODY" technology and can target two immune checkpoint molecules at the same time: PD-1 and CTLA-4.
results show that PD-1 and CTLA-4 combined blocking is effective and less toxic.
, the drug is currently being used in phase IB/II and Phase II clinical trials in China and Australia for a variety of adaptations.
, Chairman and CEO of Kangfang Bio, said, "Ak104's fast-track title is an important milestone in the development of innovative dual-specific antibodies.
, we are encouraged that the FDA recognizes that AK104 can address serious diseases and meet the medical needs of patients with worsening cancer.
hope to continue to work closely with the FDA to bring AK104 to cervical cancer patients earlier.
"

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Crocetin27876-94-4

CAS No.: 27876-94-4

$1-1.1/G FOB

Betulinic acid472-15-1

CAS No.: 472-15-1

$1-1.1/G FOB

1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane 53-19-0

CAS No.: 53-19-0

Pharmacy Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.